Literature DB >> 21977190

Gastrointestinal manifestations in systemic autoimmune diseases.

M Cojocaru1, Inimioara Mihaela Cojocaru, Isabela Silosi, Camelia Doina Vrabie.   

Abstract

In an autoimmune disease, the immune system attacks and harms the body's own tissues. The systemic autoimmune diseases include collagen vascular diseases, the systemic vasculitides, Wegener granulomatosis, and Churg-Strauss syndrome. These disorders can involve any part of the gastrointestinal tract, hepatobiliary system and pancreas. They can cause a variety of gastrointestinal manifestations that are influenced by the pathophysiologic characteristics of the underlying disease process. There is a wide variation of gastrointestinal manifestations from these autoimmune disorders including, but not limited to: oral ulcers, dysphagia, gastroesophageal reflux disease, abdominal pain, constipation, diarrhea, fecal incontinence, pseudo-obstruction, perforation and gastrointestinal bleeding. Clinical workup should be initiated by the patient's subjective complaints. In this review, we analyze the effects of autoimmune diseases on the gastrointestinal tract.

Entities:  

Keywords:  gastrointestinal manifestations; systemic autoimmune diseases

Year:  2011        PMID: 21977190      PMCID: PMC3150032     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  29 in total

1.  Arthritis and inflammatory bowel disease.

Authors:  P Wordsworth
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

2.  Gastrointestinal involvement in polyarteritis nodosa (1986-2000): presentation and outcomes in 24 patients.

Authors:  Stuart M Levine; David B Hellmann; John H Stone
Journal:  Am J Med       Date:  2002-04-01       Impact factor: 4.965

3.  Large bowel obstruction heralding Churg-Strauss syndrome.

Authors:  Augusto Vaglio; Domenico Corradi; Nicoletta Ronda; Giovanni Garini; Carlo Buzio
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

4.  Primary antiphospholipid syndrome as a new cause of autoimmune pancreatitis.

Authors:  H L Spencer
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

Review 5.  Ankylosing spondylitis and bowel disease.

Authors:  Martin Rudwaleit; Dominique Baeten
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-06       Impact factor: 4.098

6.  Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study.

Authors:  T Hannu; L Mattila; A Siitonen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2004-11-18       Impact factor: 19.103

Review 7.  Gastrointestinal involvement in polyarteritis nodosa.

Authors:  Ellen C Ebert; Klaus D Hagspiel; Michael Nagar; Naomi Schlesinger
Journal:  Clin Gastroenterol Hepatol       Date:  2008-06-27       Impact factor: 11.382

8.  Dysphagia in a patient with lupus and review of the literature.

Authors:  S Chua; H Dodd; I T Saeed; K Chakravarty
Journal:  Lupus       Date:  2002       Impact factor: 2.911

Review 9.  Gastrointestinal lesions associated with spondyloarthropathies.

Authors:  Ambrogio Orlando; Sara Renna; Giovanni Perricone; Mario Cottone
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

10.  Lymphocytic enterocolitis in systemic lupus erythematosus.

Authors:  Mohamed O Hegazi; Salem F Owayed; Mohamed Mourou; Munish Joneja; Anant Mashankar
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more
  13 in total

Review 1.  Enteric neuroplasticity and dysmotility in inflammatory disease: key players and possible therapeutic targets.

Authors:  Estelle T Spear; Gary M Mawe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-10-11       Impact factor: 4.052

2.  Gastrointestinal comorbidities in patients with psoriatic arthritis.

Authors:  Ariel Zohar; Arnon Dov Cohen; Haim Bitterman; Ilan Feldhamer; Sari Greenberg-Dotan; Idit Lavi; Doron Comanesther; Erez Batat; Devy Zisman
Journal:  Clin Rheumatol       Date:  2016-08-17       Impact factor: 2.980

3.  Genetic Deletion of LRP5 and LRP6 in Macrophages Exacerbates Colitis-Associated Systemic Inflammation and Kidney Injury in Response to Intestinal Commensal Microbiota.

Authors:  Indumathi Manoharan; Daniel Swafford; Arulkumaran Shanmugam; Nikhil Patel; Puttur D Prasad; Riyaz Mohamed; Qingqing Wei; Zheng Dong; Muthusamy Thangaraju; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2022-06-27       Impact factor: 5.426

Review 4.  Gastric presentation (vasculitis) mimics a gastric cancer as initial symptom in granulomatosis with polyangiitis: a case report and review of the literature.

Authors:  Zhaohui Zheng; Jin Ding; Xueyi Li; Zhenbiao Wu
Journal:  Rheumatol Int       Date:  2015-08-07       Impact factor: 2.631

Review 5.  Pediatric autoimmune disorders with gastrointestinal expressions: from bench to bedside.

Authors:  Paola Francalanci; Barbara Cafferata; Rita Alaggio; Paola de Angelis; Antonella Diamanti; Paola Parente; Massimo Granai; Stefano Lazzi
Journal:  Pathologica       Date:  2021-12-02

6.  A case of systemic lupus erythematosus presenting with an acute abdomen: successful treatment with steroid.

Authors:  Haruka Fukatsu; Seisuke Ota; Koichi Sugiyama; Akinori Kasahara; Tadashi Matsumura
Journal:  Case Rep Med       Date:  2014-12-14

7.  Th17 cells reflect colon submucosal pathologic changes in active eosinophilic granulomatosis with polyangiitis.

Authors:  Naomi Tsurikisawa; Chiyako Oshikata; Takahiro Tsuburai; Satoshi Sugano; Yoko Nakamura; Takuya Shimoda; Shunpei Tamama; Ken Adachi; Ayako Horita; Ikuo Saito; Hiroshi Saito
Journal:  BMC Immunol       Date:  2015-12-29       Impact factor: 3.615

8.  Evaluation of Nutritional Status and Methods to Identify Nutritional Risk in Rheumatoid Arthritis and Spondyloarthritis.

Authors:  Marie Njerve Olsen; Randi J Tangvik; Anne-Kristine Halse
Journal:  Nutrients       Date:  2020-11-21       Impact factor: 5.717

9.  Systemic autoimmune disease as a cause of death: mortality burden and comorbidities.

Authors:  Marianna Mitratza; Bart Klijs; A Elisabeth Hak; Jan W P F Kardaun; Anton E Kunst
Journal:  Rheumatology (Oxford)       Date:  2021-03-02       Impact factor: 7.580

10.  Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study.

Authors:  Bernhard Manger; Falk Hiepe; Matthias Schneider; Margitta Worm; Peter Wimmer; Eva-Maria Paulus; Andreas Schwarting
Journal:  Clin Exp Gastroenterol       Date:  2015-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.